TSX News -
Sabina Completes $28.1 Million Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Supports Continued De-Risking Activities for […]
Wayland Update on 3:1 reverse stock split & AGM Results
TORONTO, Dec. 21, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) announces that the […]
Align Technology Receives Multiple Product Awards for iTero Element 2 and iTero Element Flex Scanners
SAN JOSE, Calif., Dec. 21, 2018 (GLOBE NEWSWIRE) — Align Technology, Inc. (NASDAQ: ALGN) announced today that the iTero Element […]
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
WEST DES MOINES, Iowa, Dec. 21, 2018 (GLOBE NEWSWIRE) — West Bancorporation, Inc. (Nasdaq: WTBA) (the “Company”), parent company of […]
PotlatchDeltic Announces Agreement to Sell El Dorado MDF
SPOKANE, Wash., Dec. 21, 2018 (GLOBE NEWSWIRE) — PotlatchDeltic Corporation (NASDAQ: PCH) today announced an agreement to sell its El […]
Insight Brings VR Holiday Experience to Children at Tampa General Hospital
Digital Innovation expert designs immersive sleigh ride with Santa for pediatric patients unable to enjoy holidays at home TEMPE, Ariz., […]
TSX News -
Microbix Reports Results for Fiscal 2018
Full-Year Sales Growth of 23%, Progress Toward Sustained Profitability TORONTO, Dec. 21, 2018 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: […]
ExGen Announces Increase to and Closing of Unit Private Placement, and Change of Auditor
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 21, […]
TRACON Pharmaceuticals Announces Top-line Data from Phase 2 TRAXAR Clinical Trial in Renal Cell Carcinoma
SAN DIEGO, Dec. 21, 2018 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development […]
Abattis Provides Marketing and Operational Updates
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) is pleased […]
